[
  {
    "company_name": "Archer-Daniels-Midland Company",
    "symbol": "ADM",
    "overall_sentiment": "positive",
    "financials": {
      "revenue_growth": "mid-single digit",
      "eps_change": "1.46 USD",
      "outlook_summary": "Expects revenue growth in the mid-single digit range for the full year, with operating profit expected to be slightly better due to cost reductions."
    },
    "executives": [
      {
        "name": "Juan Luciano",
        "role": "Board Chair and Chief Executive Officer",
        "sentiment": "positive"
      },
      {
        "name": "Ismael Roig",
        "role": "Interim Chief Financial Officer",
        "sentiment": "positive"
      },
      {
        "name": "Megan Britt",
        "role": "Host",
        "sentiment": "neutral"
      }
    ],
    "technologies": [
      {
        "technology_name": "AI",
        "technology_sentiment": "positive",
        "investment_action": "unclear",
        "investment_horizon": "unclear",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Chatbot",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "improving operating performance",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "1ADM",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "improved volumes delivered sequentially",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "regenerative ag",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "long-term",
        "profit_outlook": "high potential",
        "rd_investment": "increased goal to 5 million acres by 2025",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "bio solutions",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "nearly 10% volume growth in Q1",
        "mentioned_by": "Juan Luciano"
      }
    ],
    "year": 2024,
    "quarter": 1,
    "date": "2024-04-30 09:00:00"
  },
  {
    "company_name": "Archer-Daniels-Midland Company",
    "symbol": "ADM",
    "overall_sentiment": "positive",
    "financials": {
      "revenue_growth": "+3%",
      "outlook_summary": "Expects solid demand through 2024, with potential upside in AS&O. Nutrition business expects a return to growth that will continue and expand in 2025. Anticipates significant portion of $500 million cost savings to be realized by end of initial year.",
      "cost_savings": "$500 million"
    },
    "executives": [
      {
        "name": "Juan Luciano",
        "role": "Chairman and Chief Executive Officer",
        "sentiment": "positive"
      },
      {
        "name": "Ismael Roig",
        "role": "Chief Financial Officer (Interim) / EMEA and Animal Nutrition Lead",
        "sentiment": "positive"
      },
      {
        "name": "Megan Britt",
        "role": "Vice President, Investor Relations",
        "sentiment": "neutral"
      }
    ],
    "technologies": [
      {
        "technology_name": "Digital Technologies",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Regen Act Programs",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "BioSolutions Platform",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "high potential",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Plant Protein",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "short-term",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Ismael Roig"
      },
      {
        "technology_name": "Ethanol",
        "technology_sentiment": "positive",
        "investment_action": "unclear",
        "investment_horizon": "unclear",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Manav Gupta"
      },
      {
        "technology_name": "Sweeteners and Starches",
        "technology_sentiment": "positive",
        "investment_action": "unclear",
        "investment_horizon": "unclear",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Manav Gupta"
      },
      {
        "technology_name": "Flavors",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "moderate potential",
        "rd_investment": "unclear",
        "revenue_impact": "+6%",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Health and Wellness",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "moderate potential",
        "rd_investment": "unclear",
        "revenue_impact": "+6%",
        "mentioned_by": "Juan Luciano"
      }
    ],
    "year": 2024,
    "quarter": 2,
    "date": "2024-07-30 09:00:00"
  },
  {
    "company_name": "Archer-Daniels-Midland Company",
    "symbol": "ADM",
    "overall_sentiment": "neutral",
    "financials": {
      "outlook_summary": "Adjusted EPS guidance lowered to $4.50-$5.00 per share for FY24 due to slow market demand and internal operational challenges. Corporate costs expected between $1.7B-$1.8B. Net interest expense $475M-$525M. Capital expenditures approximately $1.5B. Effective tax rate increased to 20%-22%.",
      "eps_change": "guidance lowered",
      "rd_investment_change": "Automation and digitization efforts accelerated, scope increased across plants."
    },
    "executives": [
      {
        "name": "Juan Luciano",
        "role": "Chair of the Board and Chief Executive Officer",
        "sentiment": "neutral"
      },
      {
        "name": "Monish Patolawala",
        "role": "EVP and Chief Financial Officer",
        "sentiment": "neutral"
      },
      {
        "name": "Megan Britt",
        "role": "Vice President, Investor Relations",
        "sentiment": "neutral"
      }
    ],
    "technologies": [
      {
        "technology_name": "regen ag",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "supporting supply and demand needs",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "BioSolutions",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Automation",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "millions in cost savings",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Digitization",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "millions in cost savings",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "Human Nutrition",
        "technology_sentiment": "neutral",
        "investment_action": "unclear",
        "investment_horizon": "unclear",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Tom Palmer"
      },
      {
        "technology_name": "Animal Nutrition",
        "technology_sentiment": "neutral",
        "investment_action": "unclear",
        "investment_horizon": "unclear",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "improved profitability",
        "mentioned_by": "Tom Palmer"
      }
    ],
    "year": 2024,
    "quarter": 3,
    "date": "2024-12-03 09:00:00"
  },
  {
    "company_name": "Archer-Daniels-Midland Company",
    "symbol": "ADM",
    "overall_sentiment": "neutral",
    "financials": {
      "eps_change": "in line with guidance",
      "outlook_summary": "Entered 2025 with focus on internal execution, cost management, strategic simplification, strategic growth, and capital discipline to ensure optionality in short, medium, and long term.",
      "segment_operating_profit_change": "AS&O down 32% in Q4, 40% for full-year; Ag Services down 39% for full-year.",
      "roic": "8.3%"
    },
    "executives": [
      {
        "name": "Juan Luciano",
        "role": "Chair of the Board and Chief Executive Officer",
        "sentiment": "positive"
      },
      {
        "name": "Monish Patolawala",
        "role": "EVP and Chief Financial Officer",
        "sentiment": "neutral"
      },
      {
        "name": "Megan Britt",
        "role": "Vice President, Investor Relations",
        "sentiment": "neutral"
      }
    ],
    "technologies": [
      {
        "technology_name": "biosolutions",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "supporting growing customer demand",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "health & wellness",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "supporting growing customer demand",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "data analytics",
        "technology_sentiment": "positive",
        "investment_action": "investing",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "identify and assess new savings opportunities quickly",
        "mentioned_by": "Juan Luciano"
      },
      {
        "technology_name": "digital capabilities",
        "technology_sentiment": "positive",
        "investment_action": "maintaining",
        "investment_horizon": "ongoing",
        "profit_outlook": "unclear",
        "rd_investment": "unclear",
        "revenue_impact": "unclear",
        "mentioned_by": "Juan Luciano"
      }
    ],
    "year": 2024,
    "quarter": 4,
    "date": "2025-02-04 10:00:00"
  }
]